NASDAQ:BCLI - Brainstorm Cell Therapeutics News Headlines

$3.99
-0.07 (-1.72 %)
(As of 07/19/2019 04:00 PM ET)
Today's Range
$3.88
Now: $3.99
$4.13
50-Day Range
$3.56
MA: $3.93
$4.48
52-Week Range
$2.92
Now: $3.99
$4.50
Volume90,614 shs
Average Volume82,470 shs
Market Capitalization$86.58 million
P/E RatioN/A
Dividend YieldN/A
Beta1.23

Headlines

Brainstorm Cell Therapeutics (NASDAQ BCLI) News Headlines

Source:
DateHeadline
Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) Sees Significant Decline in Short InterestBrainstorm Cell Therapeutics Inc (NASDAQ:BCLI) Sees Significant Decline in Short Interest
www.americanbankingnews.com - July 11 at 11:13 PM
If You Had Bought Brainstorm Cell Therapeutics (NASDAQ:BCLI) Stock Three Years Ago, You Could Pocket A 59% Gain TodayIf You Had Bought Brainstorm Cell Therapeutics (NASDAQ:BCLI) Stock Three Years Ago, You Could Pocket A 59% Gain Today
finance.yahoo.com - July 10 at 8:30 AM
Third Clinical Site Initiated for BrainStorm Cell Therapeutics Phase 2 Progressive MS StudyThird Clinical Site Initiated for BrainStorm Cell Therapeutic's Phase 2 Progressive MS Study
www.marketwatch.com - July 2 at 6:40 PM
Third Clinical Site Initiated for BrainStorm Cell Therapeutic’s Phase 2 Progressive MS StudyThird Clinical Site Initiated for BrainStorm Cell Therapeutic’s Phase 2 Progressive MS Study
finance.yahoo.com - July 2 at 8:21 AM
BrainStorm Cell Therapeutics (BCLI) Presents At BIO 2019 International Convention - SlideshowBrainStorm Cell Therapeutics (BCLI) Presents At BIO 2019 International Convention - Slideshow
seekingalpha.com - June 6 at 7:07 PM
BrainStorm Presents Poster at Consortium of Multiple Sclerosis Centers (CMSC) 33rd Annual MeetingBrainStorm Presents Poster at Consortium of Multiple Sclerosis Centers (CMSC) 33rd Annual Meeting
finance.yahoo.com - May 31 at 8:22 AM
BrainStorm Announces Second Clinical Site to Enroll Patients in Its Progressive MS Phase 2 StudyBrainStorm Announces Second Clinical Site to Enroll Patients in Its Progressive MS Phase 2 Study
finance.yahoo.com - May 30 at 8:28 AM
BCLI: Enrollment in Phase 3 ALS Trial to Complete in 3Q19…BCLI: Enrollment in Phase 3 ALS Trial to Complete in 3Q19…
finance.yahoo.com - May 21 at 7:27 PM
Brainstorm Cell Therapeutics: Poor Cash And Specific Risks Make This An AvoidBrainstorm Cell Therapeutics: Poor Cash And Specific Risks Make This An Avoid
seekingalpha.com - May 16 at 7:45 PM
BrainStorm Cell Therapeutics misses by $0.13BrainStorm Cell Therapeutics misses by $0.13
seekingalpha.com - May 10 at 6:55 PM
BrainStorm’s Cellular Technology Platform Expanded to Include Exosomes for Neurodegenerative DiseasesBrainStorm’s Cellular Technology Platform Expanded to Include Exosomes for Neurodegenerative Diseases
finance.yahoo.com - April 30 at 8:17 AM
BCLI: Two Abstracts to be Presented at AAN Annual Meeting…BCLI: Two Abstracts to be Presented at AAN Annual Meeting…
finance.yahoo.com - April 4 at 8:07 PM
Two BrainStorm Scientific Abstracts Accepted for Presentation at the 71st American Academy of Neurology Annual MeetingTwo BrainStorm Scientific Abstracts Accepted for Presentation at the 71st American Academy of Neurology Annual Meeting
finance.yahoo.com - March 28 at 8:29 AM
BrainStorm Announces Grant of an additional New European Patent for NurOwn®BrainStorm Announces Grant of an additional New European Patent for NurOwn®
finance.yahoo.com - March 26 at 8:31 AM
Atlas Blockchain Announces Definitive Agreement for the Acquisition of Isracann and Amendment to Investor Services AgreementAtlas Blockchain Announces Definitive Agreement for the Acquisition of Isracann and Amendment to Investor Services Agreement
finance.yahoo.com - March 19 at 8:37 AM
Brainstorm Cell Therapeutics (BCLI) Reports First Patient Enrolled in Phase 2 Clinical Trial of Progressive MS - StreetInsider.comBrainstorm Cell Therapeutics (BCLI) Reports First Patient Enrolled in Phase 2 Clinical Trial of Progressive MS - StreetInsider.com
www.streetinsider.com - March 15 at 7:29 PM
BCLI: Hospital Exemption Approved in Israel; First Patient Enrolled in Phase 2 Study in Progressive MS…BCLI: Hospital Exemption Approved in Israel; First Patient Enrolled in Phase 2 Study in Progressive MS…
finance.yahoo.com - March 15 at 7:29 PM
BrainStorm Announces First Patient Enrolled in Phase 2 Clinical Trial of Progressive MSBrainStorm Announces First Patient Enrolled in Phase 2 Clinical Trial of Progressive MS
finance.yahoo.com - March 14 at 8:27 AM
Breakeven On The Horizon For Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)Breakeven On The Horizon For Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)
finance.yahoo.com - March 13 at 7:07 PM
Brainstorm Cell Therapeutics (BCLI) Reports First Contracted US Clinical Site for Phase 2 Progressive MS Study - StreetInsider.comBrainstorm Cell Therapeutics (BCLI) Reports First Contracted US Clinical Site for Phase 2 Progressive MS Study - StreetInsider.com
www.streetinsider.com - February 23 at 6:11 PM
BrainStorm Announces First Contracted U.S. Clinical Site for Phase 2 Progressive MS StudyBrainStorm Announces First Contracted U.S. Clinical Site for Phase 2 Progressive MS Study
finance.yahoo.com - February 22 at 8:22 AM
BrainStorm to Present at 2019 Sachs Associates European Life Sciences CEO Forum in Zurich, SwitzerlandBrainStorm to Present at 2019 Sachs Associates European Life Sciences CEO Forum in Zurich, Switzerland
finance.yahoo.com - February 21 at 8:28 AM
BrainStorm Issues a Statement to Patients and ShareholdersBrainStorm Issues a Statement to Patients and Shareholders
finance.yahoo.com - February 19 at 8:16 AM
BrainStorm to Present at 2019 BIO CEO & Investor Conference and Extracellular Vesicles in Diagnostics & Therapeutics SymposiumBrainStorm to Present at 2019 BIO CEO & Investor Conference and Extracellular Vesicles in Diagnostics & Therapeutics Symposium
finance.yahoo.com - February 5 at 7:16 AM
BrainStorm Cell Therapeutics to Present at the 2019 NobleCon15 Annual Investor Conference in Fort Lauderdale, FloridaBrainStorm Cell Therapeutics to Present at the 2019 NobleCon15 Annual Investor Conference in Fort Lauderdale, Florida
finance.yahoo.com - January 25 at 8:18 AM
BrainStorm Granted Additional Patent for NurOwn® in IsraelBrainStorm Granted Additional Patent for NurOwn® in Israel
finance.yahoo.com - January 22 at 6:24 PM
BCLI: Initiating Phase 2 Study in Progressive Multiple Sclerosis…BCLI: Initiating Phase 2 Study in Progressive Multiple Sclerosis…
finance.yahoo.com - January 7 at 6:23 PM
BrainStorm Issues 2018 Letter to ShareholdersBrainStorm Issues 2018 Letter to Shareholders
finance.yahoo.com - December 27 at 8:28 AM
BrainStorm Expands Manufacturing of NurOwn® for Phase 2 Progressive MS TrialBrainStorm Expands Manufacturing of NurOwn® for Phase 2 Progressive MS Trial
finance.yahoo.com - December 26 at 8:22 AM
Brainstorm (BCLI) Announces FDA Accepted its NurOwn IND Application for Progressive Multiple SclerosisBrainstorm (BCLI) Announces FDA Accepted its NurOwn IND Application for Progressive Multiple Sclerosis
www.streetinsider.com - December 17 at 5:44 PM
BrainStorm gets FDA okay for stem cell trial in MS patientsBrainStorm gets FDA okay for stem cell trial in MS patients
finance.yahoo.com - December 17 at 8:17 AM
FDA Accepts BrainStorm’s NurOwn® IND Application for Progressive Multiple SclerosisFDA Accepts BrainStorm’s NurOwn® IND Application for Progressive Multiple Sclerosis
finance.yahoo.com - December 17 at 8:17 AM
BrainStorm Cell Therapeutics to Present at the 29th International Symposium on ALS/MNDBrainStorm Cell Therapeutics to Present at the 29th International Symposium on ALS/MND
finance.yahoo.com - December 4 at 8:24 AM
Do Institutions Own Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) Shares?Do Institutions Own Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) Shares?
finance.yahoo.com - December 3 at 5:15 PM
Detailed Research: Economic Perspectives on Stellar Biotechnologies, MAM Software Group, EverQuote, Brainstorm ...Detailed Research: Economic Perspectives on Stellar Biotechnologies, MAM Software Group, EverQuote, Brainstorm ...
globenewswire.com - November 22 at 8:19 AM
Brainstorm files IND for mid-stage study of NurOwn in progressive MSBrainstorm files IND for mid-stage study of NurOwn in progressive MS
seekingalpha.com - November 21 at 8:18 AM
Brainstorm Cell Therapeutics (BCLI) Announces Submission of IND for NurOwn in Progressive MSBrainstorm Cell Therapeutics (BCLI) Announces Submission of IND for NurOwn in Progressive MS
www.streetinsider.com - November 20 at 8:17 AM
BrainStorm Cell Therapeutics Announces Submission of IND for NurOwn® in Progressive Multiple SclerosisBrainStorm Cell Therapeutics Announces Submission of IND for NurOwn® in Progressive Multiple Sclerosis
finance.yahoo.com - November 19 at 8:18 AM
BrainStorm Cell Therapeutics to Present at November Clinical and Investor ConferencesBrainStorm Cell Therapeutics to Present at November Clinical and Investor Conferences
finance.yahoo.com - November 7 at 8:18 AM
BCLI: Phase 3 Trial to Be Fully Enrolled by Mid-2019…BCLI: Phase 3 Trial to Be Fully Enrolled by Mid-2019…
finance.yahoo.com - October 30 at 5:33 PM
BrainStorm Cell Therapeutics net loss widens in Q3BrainStorm Cell Therapeutics net loss widens in Q3
seekingalpha.com - October 29 at 5:03 PM
BrainStorm Announces Financial Results for the Third Quarter of 2018 and Provides a Corporate UpdateBrainStorm Announces Financial Results for the Third Quarter of 2018 and Provides a Corporate Update
finance.yahoo.com - October 29 at 5:03 PM
BrainStorm to Announce Third Quarter Financial Results and Provide Corporate Update on Monday, October 29BrainStorm to Announce Third Quarter Financial Results and Provide Corporate Update on Monday, October 29
finance.yahoo.com - October 17 at 4:58 PM
Form DEF 14A BRAINSTORM CELL THERAPEU For: Nov 29Form DEF 14A BRAINSTORM CELL THERAPEU For: Nov 29
www.streetinsider.com - October 11 at 8:18 AM
BrainStorm Poster Receives Clinical Abstract Award at NEALS ConferenceBrainStorm Poster Receives Clinical Abstract Award at NEALS Conference
globenewswire.com - October 4 at 4:53 PM
Does Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) Fall With The Market?Does Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) Fall With The Market?
finance.yahoo.com - October 4 at 4:53 PM
BrainStorm Highlights Translational Data and Presentations Supporting NUROWN® Technology Platform as a Best-In ...BrainStorm Highlights Translational Data and Presentations Supporting NUROWN® Technology Platform as a Best-In ...
globenewswire.com - October 4 at 8:15 AM
BrainStorm Highlights Translational Data and Presentations Supporting NUROWN® Technology Platform as a Best-In-Class Strategy in ALSBrainStorm Highlights Translational Data and Presentations Supporting NUROWN® Technology Platform as a Best-In-Class Strategy in ALS
finance.yahoo.com - October 3 at 8:21 AM
Brainstorm Cell Therapeutics (BCLI) Announces New U.S. Patent for Industrial Scale Manufacturing of NurOwnBrainstorm Cell Therapeutics (BCLI) Announces New U.S. Patent for Industrial Scale Manufacturing of NurOwn
www.streetinsider.com - September 13 at 4:54 PM
BrainStorm Granted New U.S. Patent for Industrial Scale Manufacturing of NurOwn®BrainStorm Granted New U.S. Patent for Industrial Scale Manufacturing of NurOwn®
finance.yahoo.com - September 13 at 8:25 AM
This page was last updated on 7/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel